the dermoscopy and confocal microscopy findings were inconsistent with the diagnosis of a nevus, we opted for an excisional biopsy under local anesthesia during the 18th week of pregnancy. Histology revealed a sharply demarcated, relatively symmetrical compound melanocytic lesion. Pigmented parakeratosis was focally present as a sign of irritation. Worrisome features reminiscent of melanoma were observed in the intraepidermal compartment of the lesion and included the com bination of nests of irregular shape and size and focal suprabasal pagetoid spreading of single cells. Most of the junctional melanocytes were heavily pigmented and had long, prominent dendrites; moreover, some melanocytes had hyperchromatic large nuclei and an abundant cytoplasm.
These findings in the epidermis are usually consistent with the diagnosis of a malignant melanocytic proliferation and are usually not in favor of benign growth. However, regarding the dermal component of the lesion, histopathology showed nests and cords of morphologically inconspicuous mature melanocytes without mitoses. Overall, from the histopathology findings and the clinical information on the special localization of the lesion, the final diagnosis was consistent with an irritated compound nevus of the milk line with signs of dysplasia and fibrosis ( fig. 4 ) .
Discussion
We present an unusual case of a changing nevus of the nipple during pregnancy which caused a diagnostic pitfall.
Nevi on the nipple and areola are infrequent, and diagnostic criteria whether for clinical, dermoscopy or confocal microscopy examination for nevi in this 'special location ' have not yet been established.
Only a few cases of melanoses of the areola are reported in the literature [1] [2] [3] . Blum et al. [3] described the dermoscopic findings in a case of melanosis of the areola. They found that the hyperpigmentation was arranged in a cobblestone pattern due to the anatomy of the normal skin of the areola. Interestingly, the change in color and size of the lesion reported by Blum et al. coincided also with pregnancy of the patient. So far there are only 2 reports in the literature dealing with the correlation of dermoscopy, histopathology and in vivo RCM findings in mammary lesions: one on mammary Paget's disease [4] and another -recently published by Zrinjka et al. [5] -on findings in a congenital nevus of the nipple. As in our case, dermoscopy showed an irregular black globular pattern. Zrinjka et al. [5] nicely correlate their findings: RCM revealed irregular dense junctional nests, multiple melanophages in the upper dermis and the absence of pagetoid spreading. The final diagnosis of congenital nevus was therefore made by histopathology, especially with the positive immunostaining for melanophages; clinical findings alone were not conclusive either [5] .
Driscoll and Grant-Kels [6] published a review on changes of nevi and melanoma during pregnancy. They concluded that a changing pigmented lesion in the pregnant woman should be approached in the same way as in any patient. Most dermoscopic changes are due to the physiological extension of the skin during pregnancy [7, 8] . Only pregnant women with dysplastic nevus syndrome require closer monitoring; their nevi tend to have a higher rate of clinical change during pregnancy [9] . Melanoma incidence is not higher during pregnancy; neither does pregnancy adversely affect survival or prognosis of melanoma [6] . Excisions under local anesthesia can be performed safely at any moment, especially after the third month of pregnancy [6] .
This case is interesting because it demonstrates two main problems of misinterpretation of RCM images of melanocytic lesions. Primarily we misinterpreted the single highly refractile dendritic cells in dermal-epidermal junction and upper dermis. In our case, the RCM findings of multiple dendritic cells in the suprabasal layer of the epidermis and single strong refractile round cells and dense cell nests above the dermal-epidermal junction led us to overdiagnose the lesion in favor of melanoma. Zrinjka et al. [5] mentioned that they also had to deal with the limitation in depth. Examination of the lower dermis was not accessible by RCM means, which may have changed our opinion towards benignity of the lesion. Histopathologically the intraepidermal component of nevi situated along the milk line (nipple, areola, axilla, umbilicus and groin) often shows, similarly to genital nevi, architectural and cytological irregularities simulating melanoma; they are known in the dermatopathological literature as 'special location' nevi [12, 13] . Such lesions can be very challenging for the dermatopathologist.
The accurate evaluation of the maturation of cells in the dermal component and the consideration of the localization are essential for the correct histopathological diagnosis of these lesions.
With more reports in the literature on mammary lesions, patterns for this special anatomic site will be recognized, allowing us to have more confidence in in vivo diagnostic means, like dermoscopy and RCM.
the lower epidermis to be of melanocytic origin. As mentioned before, pagetoid spreading is a hallmark criterion for melanoma [10] . Differentiation of dendritic melanocytes from activated Langerhans cells by RCM is difficult and often not possible. So far, the distinction between dendritic melanocytes and Langerhans cells is currently only possible by immunohistochemistry. CD1a staining of our case proved that the intraepidermal dendritic cells were in fact Langerhans cells ( fig. 5 ). An explanation for the finding of multiple Langerhans cells might be the pregnancy of our patient. It is estimated that only 3-5% of the epi dermal cells are Langerhans cells, but it has been demonstrated that progesterone is able to increase the absolute number of Langerhans cells in different epithelial cells [11] .
Secondly, RCM allows the examination of the skin at a quasi histological resolution to a depth of 200-250 m depending on the level of keratinization of the skin. Therefore, RCM diagnosis is normally based on the findings in the epidermis, 
Erratum
In the article by Reich et al. [Dermatology 2010 ;221:172-178], entitled 'Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS trial', in table 3 on page 175, there was an unintentional error pertaining to median DLQI improvement percentages. Specifically, the mean DLQI improvement percentages for week 38 scores, i.e. 92.9% for all, 100.0% for PASI-75 responders and 100.0% for PASI-90 responders, should not have been included. The data points in the table should be replaced by dashes because there were no DLQI assessments at that time point in the EXPRESS study. The error did not affect the interpretation or conclusions of the study.
